Team: Bios

Luke Evnin, PhD Managing Director
Luke Evnin, PhD

Dr. Luke Evnin co-founded MPM's asset management business in 1997 to launch MPM's first venture fund and established the San Francisco office for the firm in 1999. Dr. Evnin was at Accel Partners for over seven years including four as a General Partner. He was involved in biopharmaceutical, medical device and healthcare service companies for Accel's funds III, IV and V. Dr. Evnin earned his Ph.D. in the Department of Biochemistry at the University of California-San Francisco, and he received his A.B. in Molecular Biology magna cum laude from Princeton University.

Present Boards
Amphivena Therapeutics, Inc.
Costim Pharmaceuticals, Inc.
Enteromedics, Inc. (NASDAQ:ETRM)
Oxagen Limited
Syndax Pharmaceuticals, Inc. 

Past Boards
Epic Therapeutics, Inc.
EPIX Pharmaceuticals, Inc. (NASDAQ:EPIX)
Idun Pharmaceuticals, Inc.
Intercell AG (VSE:ICLL)
Metabasis Therapeutics, Inc. (NASDAQ:MBRX)
NeuroTherapeutics Pharma, Inc.
Oscient Pharmaceuticals Corp. (NASDAQ:OSCI)
Pacira Pharmaceuticals, Inc.
Peptimmune, Inc.
Signal Pharmaceuticals, Inc.
Sonic Innovations, Inc. (NASDAQ:SNCI)


Contact Us

Boston Office
The John Hancock Tower
200 Clarendon Street
54th Floor
Boston, MA 02116
Phone: 617-425-9200
Fax: 617-425-9201

San Francisco Office
601 Gateway Boulevard
Suite 350
South San Francisco, CA 94080
Phone: 650-553-3300
Fax: 650-553-3301

Munich, Germany Office
Promenadeplatz 12
80333 Munich
Phone: +49-89-43597568
Fax: +49-89-211128-128

Gainesville, FL Office
747 SW 2nd Ave.
Suite 201 IMB #1
Gainesville, FL 32601
Phone: 352-294-2715

Kansas City, Kansas Office
1901 Olathe Blvd.
Kansas City, KS  66103
Phone: 913-951-2100